Ipca Laboratories Limited Ipca Laboratories Limited

Ipca Laboratories Limited

IPCALAB

Rankning i aktier #3408
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aktiekurs
$20.16
Marknadsvärde
$5.12B
Förändring (1 dag)
0.68%
Förändring (1 år)
38.50%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)

Kategori

Healthcare
Historik för aktiesplit för Ipca Laboratories Limited (IPCALAB)
Aktien Ipca Laboratories Limited (symbol: IPCALAB) har genomgått totalt 3 aktiesplitar.
Den senaste spliten skedde den Jan 10, 2022.
En IPCALAB-aktie köpt före Jan 28, 2005 motsvarar nu 20 IPCALAB-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2022-01-10 2:1 x2 x20
2010-03-22 5:1 x5 x10
2005-01-28 2:1 x2 x2
Aktiesplitar för liknande företag eller konkurrenter